RLAY — Relay Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Relay Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	356	678	958	999	750
Net Total Accounts Receivable
Net Total Receivables	—	82.7	4.94	5.22	0
Prepaid Expenses
Total Other Current Assets
Total Current Assets	361	770	976	1,020	770
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	31.7	28.8	27.3	75.4	68.9
Net Intangible Assets
Other Long Term Assets
Total Assets	393	800	1,008	1,100	844
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	12	13.6	24.3	63.7	30.3
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	35.7	36.5	111	150	92
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	357	763	898	950	752
Total Liabilities & Shareholders' Equity	393	800	1,008	1,100	844
Total Common Shares Outstanding